Tag: NASDAQ:ACOR

Finance

Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

On 4 AUG Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that the company will host its Second Quarter 2014 Investor Conference Call on Monday, August 11. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is 12.98%. On last trading day company shares ended up $6.53. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is -5.40%. On 31 JULY Acorda Therapeutics, Inc. … Continue reading Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

Kevin Long
Finance

Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares in the last session and the average volume of the … Continue reading Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Mark DeFrance
Finance

Healthcare Unusual Volume: Edwards Lifesciences Corp (NYSE:EW), Allergan (NYSE:AGN), Akebia Therapeutics (NASDAQ:AKBA), Acorda Therapeutics (NASDAQ:ACOR)

Edwards Lifesciences Corp (NYSE:EW) climbed 11 percent after the company won a court ruling that limited the sale of Medtronic’s (MDT) CoreValve system in the US. Edwards Lifesciences Corp (NYSE:EW) stock performance was 11.00% in last session and finished the day at $81.00. Traded volume was 7.23million shares in the last session and the average volume of the stock remained 1.36million shares. The beta of … Continue reading Healthcare Unusual Volume: Edwards Lifesciences Corp (NYSE:EW), Allergan (NYSE:AGN), Akebia Therapeutics (NASDAQ:AKBA), Acorda Therapeutics (NASDAQ:ACOR)

Colin Pettis